NCT00186901View on ClinicalTrials.gov

A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors

PHASE3CompletedINTERVENTIONAL
Enrollment

429

Participants

Timeline

Start Date

July 31, 2000

Primary Completion Date

June 30, 2009

Study Completion Date

September 30, 2011

Conditions
Leukemia, Lymphoblastic, AcuteOsteoporosis
Interventions
DRUG

Calcium carbonate (Tums), vitamin D

Calcium carbonate 100mg/day (Tums), vitamin D 800 units/day

OTHER

Placebo

Placebo

Trial Locations (3)

38105

St. Jude Children's Research Hospital, Memphis

38163

Metabolic Bone Center at the University of Tennessee, Memphis

Preventive Medicine, University of Tennessee, Memphis

All Listed Sponsors
lead

St. Jude Children's Research Hospital

OTHER

NCT00186901 - A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors | Biotech Hunter | Biotech Hunter